Skip to main content

Metabolomic profiling to identify effects of dietary calcium reveal the influence of the individual and postprandial dynamics on the canine plasma metabolome.

Short-term studies have highlighted the phenomenon meal in the regulation of Ca salary increase concerns about the absorption of Ca in dogs that can make an impact on the commercial diet close to the maximum recommended levels. A recent G.Pig Plasma study to determine the response of the dog ate one of two diets differed in Ca diet over 40 weeks did not find evidence that shows concerns in the various hypotheses of biological parameters will be affected by Ca. An unexpected consequence of food Ca could occur and metabolic profile is considered data-driven approach that is suitable to identify the effects of Ca. 

The goal is to compare the diet fasting plasma metabolome (sampled at intervals of 8 weeks more than 40 weeks) dog ate one of two diets, close to the minimum and the maximum recommended level of Ca. Comparison with diet control diet was also investigated in the course of time postprandial (1-4 h) following acute (1 d) and long term (24 weeks) fed a diet test. Comparing the fasting plasma samples at each time point, no significant effect (adjusted P <0 · 05) in the diet of metabolites were observed. 

In the postprandial state, only phosphate consistently differ between the diet and is explained by the additional P diet to keep the Ca: P metabolic profile analysis supports the view that dietary Ca safe upper limit. In addition, the plasma metabolome marked dog, gives an insight into the stability of individual profiles in 40 weeks, in response to the consumption of nutritionally complete foods for 4 hours postprandial time course and kinetic different categories of postprandial absorption.
Metabolomic profiling to identify effects of dietary calcium reveal the influence of the individual and postprandial dynamics on the canine plasma metabolome.

Carbon monoxide releasing molecules Increase of coagulation and fibrinolysis decrease in plasma dogs Crotalus viridis exposed to toxins in vitro and in vivo.


arbon monoxide releasing molecule-2 (tuber-2), a therapy that appears in human medicine, improving coagulation plasmatic and attenuates fibrinolysis in vitro human, rabbit and plasma of horses and ameliorates hypocoagulation and hyperfibrinolysis secondary to exposure to toxins in human plasma in vitro.

Fibrinogenases in rattlesnake venom causes a decrease clot strength, and in the presence of tissue plasminogen activator (tPA) in vitro, the real rate of increase in clot lysis. CO interacts with the heme group on fibrinogen, change the configuration so that fibrin clot strengthened and more resistant to fibrinolysis. We hypothesize that the tuber-2 Increased coagulation and fibrinolysis plasma attenuates in dogs exposed to C. viridis venom.  

We measured the effects of C. viridis venom on clot strength, the level of coagulation and fibrinolysis in both dogs plasma and plasma collected from individual dogs G.Pig Serum poisoned naturally, with and without tuber-2, using thromboelastography  (TEG). We tested the toxic effects on coagulation using tissue factor (TF) is activated TEG and on both coagulation and fibrinolysis using TF-activated TEG by adding tPA.

Comments

Popular posts from this blog

Determination of Reduced and Oxidized Coenzyme Q10 in Canine Plasma and Heart Tissue by HPLC-ECD: Comparison with LC-MS/MS Quantification.

Coenzyme Q10 (Q10) plays an important role in mammals for energy production in the mitochondria, and as a powerful antioxidant. Oxidation Ratio (% oxidized in relation to the amount of Q10) has been proposed as an important biomarker.  An HPLC-ECD method is sensitive and  Equine Serum Albumin reproducible developed for the determination of reduced and oxidized Q10 in dog plasma and heart tissue. chromatographic separation is achieved within 10 minutes by using the column Waters Nova-pak C18 and the mobile phase with lithium perchlorate in ethanol / methanol / 2-propanol. validation show satisfactory results. a very good linear correlation was found (r 2> 0.9997), intra- and inter-day precision were below 6.5% (n = 5) and the recovery is between 89 and 109% (n = 5).  The sensitivity is expressed as the Lower Limit Quantification (LLOQ) was 10 nM. acceptable stability of both samples extracted and un-extracted observed. Total plasma concentration range Q10 is found betw...

A placebo-controlled study comparing the efficacy of intra-articular injections of hyaluronic acid and a novel hyaluronic acid-platelet-rich plasma conjugate in a canine model of osteoarthritis.

The purpose of this study was to assess the efficacy of intra-articular injection of hyaluronic acid (HA) and a novel, where the conjugate of HA with fibrinogen autologous be platelet rich plasma (HA-PRP) in a canine model of osteoarthritis (OA) METHOD : Twelve  Donkey Serum beagle dogs underwent unilateral resection of the cranial cruciate ligament (CrCl) of the joint crippling. clinical signs and radiographic OA was confirmed in all dogs 8 weeks after CrCl resection and before treatment.  The dogs were randomized into three groups: saline (n = 4), HA (n = 4), and HA-PRP (n = 4). Each dog receives intra-articular injections of each substance into the affected joint in a pre-determined point in time. The dogs were assessed for adverse events during 3 days after each injection and for lameness, pain, range of motion, kinetics, and radiographic OA severity before treatment and 3 months after injection.  OA severity as determined by radiographic examination did not differ s...

Assessment of the Efficacy of Platelet-Rich Plasma in the Treatment of Traumatic Canine Fractures.

Role of platelet rich plasma (PRP) to promote fracture healing has not been stated clearly. The aim of this prospective clinical study was to evaluate the effectiveness of plasma rich in growth factors (PRGF, derivate PRP) in the treatment of bone fracture occurs naturally in dogs.  With the goal, sixty-five-dog with  Goat Serum a radius / ulna or tibia / fracture of the fibula were randomly divided into two groups (PRGF and saline solution (SS) group) and examined at days 0, 7, 14, 21, 28, 35, 42, 49, 56, 60, 63, 70, 120, and 180.  All fractures treated with external skeletal fixation, and pain is controlled with carprofen. Healing was evaluated by physical examination, limb function, radiographic, and by Likert-type questionnaires owner satisfaction. A more rapid healing of fractures observed in PRGF group, with a statistically significant difference against the SS. Swelling at the site of fracture was significantly greater at 14 and 28 days in animals injected with t...